Top Markets
#1 ICON ICON +96.71%
#2 ZetaChain ZetaChain +46.56%
#3 Four Four +45.47%
#4 Mubarak Mubarak +33.83%
#5 World Mobile Token World Mobile Token +32.84%
#6 Phala Phala +32.67%
#7 Bitway Bitway +25.20%
#8 PumpMeme PumpMeme +24.26%
#9 The Innovation Game The Innovation Game +24.19%
#10 Pepe Pepe +23.25%
Coin of the day
ICON ICON
Settings
Language
ENGLISH
Currency
USD
Theme
Zoetis Inc. Zoetis Inc.

Zoetis Inc.

ZTS
Rank in Stocks #832
Zoetis Inc. stands as a global leader in animal health, focusing on the... Zoetis Inc. stands as a global leader in animal health, focusing on the research, development, manufacturing, and commercialization of veterinary pharmaceuticals, vaccines, and diagnostic tools. Its comprehensive portfolio serves a broad spectrum of species, encompassing both livestock, including cattle, swine, poultry, fish, and sheep, and beloved companion animals such as dogs, cats, and horses. Among its pharmaceutical offerings are various therapeutic agents. This includes vaccines, vital for preventing respiratory, gastrointestinal, and reproductive diseases by stimulating a targeted immune response; anti-infectives that combat or inhibit the proliferation of bacterial, fungal, or protozoal pathogens; and parasiticides aimed at eradicating both internal and external pests such as fleas, ticks, and various worms. Additional pharmaceuticals address areas such as pain management and sedation, anti-emesis, reproductive health, and oncology. The portfolio also features dermatological solutions for allergic skin conditions and atopic dermatitis, alongside medicated feed additives specifically designed for livestock. Beyond therapeutics, Zoetis offers an extensive array of diagnostic solutions. These include portable analysis systems for blood and urine, point-of-care testing devices, specialized instruments and reagents, rapid immunoassay kits, comprehensive reference laboratory services, and blood glucose monitoring equipment. Further extending its reach, the company provides supplementary offerings such as nutritional products, agribusiness support services, biodevices, genetic testing, and innovations in precision animal health. Zoetis distributes its diverse product portfolio to a broad customer base, including veterinary professionals, livestock producers, and retail channels. This distribution occurs directly via its sales representatives and technical specialists, as well as through partnerships with third-party veterinary distributors. Established in 1952, the company maintains its corporate headquarters in Parsippany, New Jersey.
Share Price
$71.25
Market Cap
$29.87B
Change (1 day)
-0.34%
Change (1 year)
-51.16%
Country
US
Trade Zoetis Inc. (ZTS)

Category

Healthcare
Revenue for Zoetis Inc. (ZTS)
Revenue in Jun 2026 TTM: $9.52B
According to Zoetis Inc. latest financial reports the company's current revenue (TTM) is $9.52B. In 2024 the company made a revenue of $9.26B an increase over the revenue in the year 2023 that was $8.54B. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Zoetis Inc. from 2009 to 2026
Revenue at the end of each year
Year Revenue Change
2026 (TTM) $9.52B 0.53%
2025 $9.47B 2.28%
2024 $9.26B 8.33%
2023 $8.54B 5.74%
2022 $8.08B 3.91%
2021 $7.78B 16.49%
2020 $6.68B 6.63%
2019 $6.26B 7.47%
2018 $5.83B 9.76%
2017 $5.31B 8.57%
2016 $4.89B 2.58%
2015 $4.77B -0.42%
2014 $4.79B 4.91%
2013 $4.56B 5.19%
2012 $4.34B 2.43%
2011 $4.23B 18.17%
2010 $3.58B 29.78%
2009 $2.76B 0.00%
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
 $79.67B 737.09%
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 $97.93B 928.99%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 $64.39B 576.54%
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
 $77.52B 714.53%
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
 $66.40B 597.70%
US